Ningzhi Xu
- Molecular Biology top 1%
- Cancer Research top 1%
- Oncology top 2%
- Cell Biology top 1%
- Immunology top 5%
- Co-authors
- J. Silvio GutkindPiero CrespoHongxia ZhuOmar A. CosoHidemi TeramotoJin‐Chen YuM ChiarielloToru Miki
- Topics
- Cancer-related Molecular Pathways (16 papers)MicroRNA in disease regulation (16 papers)Cancer-related gene regulation (15 papers)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Ningzhi Xu
158 papers receiving 7.2k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Molecular Biology 5.4k
- Cancer Research 1.5k
- Oncology 1.3k
- Cell Biology 1.1k
- Immunology 818
Countries citing papers authored by Ningzhi Xu
This map shows the geographic impact of Ningzhi Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ningzhi Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ningzhi Xu more than expected).
Fields of papers citing papers by Ningzhi Xu
This network shows the impact of papers produced by Ningzhi Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ningzhi Xu. The network helps show where Ningzhi Xu may publish in the future.
Co-authorship network of co-authors of Ningzhi Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Ningzhi Xu. A scholar is included among the top collaborators of Ningzhi Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ningzhi Xu. Ningzhi Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 18 | |
| 5 | 3 | |
| 6 | 43 | |
| 7 | 34 | |
| 8 | 26 | |
| 9 | 43 | |
| 10 | 10 | |
| 11 | 14 | |
| 12 | 33 | |
| 13 | 103 | |
| 14 | 33 | |
| 15 | 32 | |
| 16 | 39 | |
| 17 | 43 | |
| 18 | 42 | |
| 19 | [Survivin mutants reverse the malignancy of HeLa cells]. | 2 |
| 20 | The small GTP-binding proteins Rac1 and Cdc42regulate the activity of the JNK/SAPK signaling pathwaybreakdown → | 1508 |
About Ningzhi Xu
Ningzhi Xu is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 158 papers that have together received 7.4k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (16 papers), MicroRNA in disease regulation (16 papers) and Cancer-related gene regulation (15 papers). The work is most often cited by research in Cancer Research (1.5k citations), Molecular Biology (5.4k citations) and Cell Biology (1.1k citations). Ningzhi Xu has collaborated with scholars based in China, United States and India. Frequent co-authors include J. Silvio Gutkind, Piero Crespo, Hongxia Zhu, Omar A. Coso, Hidemi Teramoto, Jin‐Chen Yu, M Chiariello, Toru Miki, William F. Simonds and Shufang Liang. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.